EcoDrugPlus

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSSMAG00000008731
Gene Symbol: UGCG
3 Cross references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSSMAG00000018566
Gene Symbol: WEE1
3 Cross references
205 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSSMAG00000017288
Gene Symbol: YES1
3 Cross references
208 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSSMAG00000003841
Gene Symbol: ACHE
2 Cross references
231 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSSMAG00000019185
Gene Symbol: ADORA1B
2 Cross references
173 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSSMAG00000001184
Gene Symbol: ADORA2AA
3 Cross references
189 Possible Orthologues:

Adenosine A2a Receptor B

Ensembl ID : ENSSMAG00000019298
Gene Symbol: ADORA2AB
2 Cross references
198 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSSMAG00000020046
Gene Symbol: ADORA2B
1 Cross references
198 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSSMAG00000035924
Gene Symbol: ADORA2B
1 Cross references
198 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSSMAG00000018838
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSSMAG00000006698
Gene Symbol: LOC118309645
2 Cross references
204 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSSMAG00000009183
Gene Symbol: LOC118309393
2 Cross references
145 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).